Literature DB >> 22983352

Maternal allergen exposure reprograms the developmental lung transcriptome in atopic and normoresponsive rat pups.

Nicole Carpe1, Isabel Mandeville, Alvin T Kho, Weiliang Qiu, James G Martin, Kelan G Tantisira, Benjamin A Raby, Scott T Weiss, Feige Kaplan.   

Abstract

The "fetal origins hypothesis" argued that physiological changes consequent to in utero exposures ultimately contribute to disease susceptibility in later life. The dramatic increase in asthma prevalence is attributed to early exposures acting on preexisting asthma-susceptible genotypes. We showed previously that distinct transcriptome signatures distinguish the developmental respiratory phenotype of atopic (Brown Norway, BN) and normoresponsive (Lewis) rats. We aimed to determine whether maternal allergen exposure would influence asthma pathogenesis by reprogramming primary patterns of developmental lung gene expression. Postnatal offspring of dams sensitized to ovalbumin before mating and challenged during pregnancy were assessed for lung function, inflammatory biomarkers, and respiratory gene expression. Although maternal ovalbumin exposure resulted in characteristic features of an allergic response (bronchoalveolar lavage neutrophils, IgE, methacholine-induced lung resistance) in offspring of both strains, substantial strain-specific differences were observed in respiratory gene expression. Of 799 probes representing the top 5% of transcriptomic variation, only 112 (14%) were affected in both strains. Strain-specific gene signatures also exhibited marked differences in enrichment for gene ontologies, with immune regulation and cell proliferation being prominent in the BN strain, cell cycle and microtubule assembly gene sets in the Lewis strain. Multiple ovalbumin-specific probes in both strains were also differentially expressed in lymphoblastoid cell lines from human asthmatic vs. nonasthmatic sibling pairs. Our data point to the existence of distinct, genetically programmed responses to maternal exposures in developing lung. These different response patterns, if recapitulated in human fetal development, can contribute to long-term pulmonary health including interindividual susceptibility to asthma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22983352      PMCID: PMC3517678          DOI: 10.1152/ajplung.00179.2012

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  48 in total

Review 1.  Fetal and early postnatal life roots of asthma.

Authors:  Giuseppina De Luca; Francesca Olivieri; Giulia Melotti; Giulia Aiello; Luigi Lubrano; Attilio L Boner
Journal:  J Matern Fetal Neonatal Med       Date:  2010-10

2.  Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.

Authors:  Sukhbir Kaur; Gema Martin-Manso; Michael L Pendrak; Susan H Garfield; Jeff S Isenberg; David D Roberts
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

3.  Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells.

Authors:  Friederike Gieseke; Judith Böhringer; Rita Bussolari; Massimo Dominici; Rupert Handgretinger; Ingo Müller
Journal:  Blood       Date:  2010-07-19       Impact factor: 22.113

4.  Orm family proteins mediate sphingolipid homeostasis.

Authors:  David K Breslow; Sean R Collins; Bernd Bodenmiller; Ruedi Aebersold; Kai Simons; Andrej Shevchenko; Christer S Ejsing; Jonathan S Weissman
Journal:  Nature       Date:  2010-02-25       Impact factor: 49.962

5.  Expressional and functional studies of CKLF1 during dendritic cell maturation.

Authors:  Luning Shao; Ting Li; Xiaoning Mo; Otto Majdic; Yanfei Zhang; Maria Seyerl; Catharina Schrauf; Dalong Ma; Johannes Stöckl; Wenling Han
Journal:  Cell Immunol       Date:  2010-03-27       Impact factor: 4.868

6.  Genetic influences on asthma susceptibility in the developing lung.

Authors:  Nicole Carpe; Isabel Mandeville; Leslie Ribeiro; Andre Ponton; James G Martin; Alvin T Kho; Jen-Hwa Chu; Kelan Tantisira; Scott T Weiss; Benjamin A Raby; Feige Kaplan
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-29       Impact factor: 6.914

7.  Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells.

Authors:  Antonia P Popova; Paul D Bozyk; Adam M Goldsmith; Marisa J Linn; Jing Lei; J Kelley Bentley; Marc B Hershenson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-02-26       Impact factor: 5.464

8.  Tumor necrosis factor alpha drives cadherin 11 expression in rheumatoid inflammation.

Authors:  Bernard Vandooren; Tineke Cantaert; Mariëtte ter Borg; Troy Noordenbos; Rodger Kuhlman; Daniëlle Gerlag; Tim Bongartz; Kris Reedquist; Paul P Tak; Dominique Baeten
Journal:  Arthritis Rheum       Date:  2008-10

9.  Polymorphism of SERPINE2 gene is associated with pulmonary emphysema in consecutive autopsy cases.

Authors:  Koichi Fujimoto; Shinobu Ikeda; Tomio Arai; Noriko Tanaka; Toshio Kumasaka; Takeo Ishii; Kozui Kida; Masaaki Muramatsu; Motoji Sawabe
Journal:  BMC Med Genet       Date:  2010-11-10       Impact factor: 2.103

Review 10.  SP-D and regulation of the pulmonary innate immune system in allergic airway changes.

Authors:  L R Forbes; A Haczku
Journal:  Clin Exp Allergy       Date:  2010-04       Impact factor: 5.018

View more
  2 in total

1.  The lipid peroxidation product 4-hydroxynonenal inhibits NLRP3 inflammasome activation and macrophage pyroptosis.

Authors:  Chia George Hsu; Camila Lage Chávez; Chongyang Zhang; Mark Sowden; Chen Yan; Bradford C Berk
Journal:  Cell Death Differ       Date:  2022-03-09       Impact factor: 12.067

2.  Derangement of cell cycle markers in peripheral blood mononuclear cells of asthmatic patients as a reliable biomarker for asthma control.

Authors:  Mahmood Yaseen Hachim; Noha Mousaad Elemam; Rakhee K Ramakrishnan; Laila Salameh; Ronald Olivenstein; Ibrahim Yaseen Hachim; Thenmozhi Venkatachalam; Bassam Mahboub; Saba Al Heialy; Qutayba Hamid; Rifat Hamoudi
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.